{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T19:34:40Z","timestamp":1787600080016,"version":"build-2736575974"},"reference-count":69,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,22]],"date-time":"2023-02-22T00:00:00Z","timestamp":1677024000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100012802","name":"Ragon Institute of MGH, MIT and Harvard","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012802","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005294","name":"Massachusetts General Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005294","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007301","name":"Harvard University Center for AIDS Research","doi-asserted-by":"publisher","award":["P30 AI060354-02"],"award-info":[{"award-number":["P30 AI060354-02"]}],"id":[{"id":"10.13039\/100007301","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01AI146785"],"award-info":[{"award-number":["R01AI146785"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01AI153098"],"award-info":[{"award-number":["R01AI153098"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R37AI080289"],"award-info":[{"award-number":["R37AI080289"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["T32 AI007245"],"award-info":[{"award-number":["T32 AI007245"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports Medicine"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.xcrm.2023.100975","type":"journal-article","created":{"date-parts":[[2023,3,14]],"date-time":"2023-03-14T10:55:19Z","timestamp":1678791319000},"page":"100975","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Pre-existing Fc profiles shape the evolution of neutralizing antibody breadth following influenza vaccination"],"prefix":"10.1016","volume":"4","author":[{"given":"Carolyn M.","family":"Boudreau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"IV","given":"John S.","family":"Burke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander L.","family":"Roederer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew J.","family":"Gorman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophia","family":"Mundle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Lingwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Delagrave","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saranya","family":"Sridhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ted M.","family":"Ross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry","family":"Kleanthous","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Galit","family":"Alter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xcrm.2023.100975_bib1","series-title":"Past Seasons Vaccine Effectiveness Estimates","year":"2020"},{"key":"10.1016\/j.xcrm.2023.100975_bib2","series-title":"Disease Burden of Influenza","year":"2018"},{"key":"10.1016\/j.xcrm.2023.100975_bib3","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.coviro.2011.08.002","article-title":"Influenza virus vaccines : lessons from the 2009 H1N1 pandemic","volume":"1","author":"Broadbent","year":"2011","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.xcrm.2023.100975_bib4","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/infdis\/jiy103","article-title":"A universal influenza vaccine: the strategic plan for the National Institute of allergy and infectious diseases","volume":"218","author":"Erbelding","year":"2018","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.xcrm.2023.100975_bib5","first-page":"767","article-title":"The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses","volume":"70","author":"Hobson","year":"1972","journal-title":"J.\u00a0Hyg."},{"key":"10.1016\/j.xcrm.2023.100975_bib6","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1093\/infdis\/jir661","article-title":"Influenza hemagglutination-inhibition antibody titer as a correlate of vaccine-induced protection","volume":"204","author":"Ohmit","year":"2011","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.xcrm.2023.100975_bib7","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/s41577-019-0143-6","article-title":"The human antibody response to influenza A virus infection and vaccination","volume":"19","author":"Krammer","year":"2019","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.xcrm.2023.100975_bib8","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3390\/vaccines6030036","article-title":"The role of Fc gamma receptors in broad protection against influenza viruses","volume":"6","author":"Thulin","year":"2018","journal-title":"Vaccines"},{"key":"10.1016\/j.xcrm.2023.100975_bib9","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1056\/NEJMoa1315727","article-title":"Efficacy of high-dose versus standard-dose influenza vaccine in older adults","volume":"371","author":"DiazGranados","year":"2014","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.xcrm.2023.100975_bib10","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.virusres.2004.02.025","article-title":"Immunogenicity and protective efficacy of influenza vaccination","volume":"103","author":"Hannoun","year":"2004","journal-title":"Virus Res."},{"key":"10.1016\/j.xcrm.2023.100975_bib11","doi-asserted-by":"crossref","first-page":"228ra38","DOI":"10.1126\/scitranslmed.3007736","article-title":"Polyfunctional Fc-effector profiles mediated by IgG subclass selection distinguish RV144 and VAX003 vaccines","volume":"6","author":"Chung","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.xcrm.2023.100975_bib12","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1038\/s41591-018-0161-0","article-title":"Route of immunization defines multiple mechanisms of vaccine-mediated protection against SIV","volume":"24","author":"Ackerman","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2023.100975_bib13","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.chom.2018.07.009","article-title":"A role for Fc function in therapeutic monoclonal antibody-mediated protection against ebola virus","volume":"24","author":"Gunn","year":"2018","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.xcrm.2023.100975_bib14","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1084\/jem.170.4.1369","article-title":"Structure and expression of human IgG (FcRII(CD32). Functional heterogeneity is encoded by the alternatively spliced products of multiple genes","volume":"170","author":"Brooks","year":"1989","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.xcrm.2023.100975_bib15","doi-asserted-by":"crossref","first-page":"5468","DOI":"10.1128\/JVI.03403-12","article-title":"Enhanced phagocytic activity of HIV-specific antibodies correlates with natural production of immunoglobulins with skewed affinity for Fc\u03b3R2a and Fc\u03b3R2b","volume":"87","author":"Ackerman","year":"2013","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.xcrm.2023.100975_bib16","doi-asserted-by":"crossref","first-page":"e0157722","DOI":"10.1128\/mbio.01577-22","article-title":"The kinetics of SARS-CoV-2 antibody development is associated with clearance of RNAemia","volume":"13","author":"Wang","year":"2022","journal-title":"mBio"},{"key":"10.1016\/j.xcrm.2023.100975_bib17","doi-asserted-by":"crossref","first-page":"e8747","DOI":"10.15252\/msb.20188747","article-title":"Antibody Fab-Fc properties outperform titer in predictive models of SIV vaccine-induced protection","volume":"15","author":"Pittala","year":"2019","journal-title":"Mol. Syst. Biol."},{"key":"10.1016\/j.xcrm.2023.100975_bib18","doi-asserted-by":"crossref","first-page":"3926","DOI":"10.1016\/j.molimm.2008.06.027","article-title":"Inhibition of B cell receptor-mediated activation of primary human B cells by coengagement of CD19 and Fc\u03b3RIIb with Fc-engineered antibodies","volume":"45","author":"Chu","year":"2008","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.xcrm.2023.100975_bib19","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/imr.12350","article-title":"Mouse and human FcR effector functions","volume":"268","author":"Bruhns","year":"2015","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.xcrm.2023.100975_bib20","doi-asserted-by":"crossref","first-page":"328","DOI":"10.3390\/vaccines1030328","article-title":"Isotype diversification of IgG antibodies to HIV gag proteins as a therapeutic vaccination strategy for HIV infection","volume":"1","author":"French","year":"2013","journal-title":"Vaccines"},{"key":"10.1016\/j.xcrm.2023.100975_bib21","doi-asserted-by":"crossref","first-page":"eabd3601","DOI":"10.1126\/scitranslmed.abd3601","article-title":"Preexisting immunity shapes distinct antibody landscapes after influenza virus infection and vaccination in humans","volume":"12","author":"Dugan","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.xcrm.2023.100975_bib22","doi-asserted-by":"crossref","first-page":"e1005692","DOI":"10.1371\/journal.ppat.1005692","article-title":"Multi-epitope models explain how pre-existing antibodies affect the generation of broadly protective responses to influenza","volume":"12","author":"Zarnitsyna","year":"2016","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.xcrm.2023.100975_bib23","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1126\/science.1222908","article-title":"Highly conserved protective epitopes on influenza B viruses","volume":"337","author":"Dreyfus","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2023.100975_bib24","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1126\/science.aac7263","article-title":"A stable trimeric influenza hemagglutinin stem as a broadly protective immunogen","volume":"349","author":"Impagliazzo","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2023.100975_bib25","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.immuni.2021.03.009","article-title":"A Fc engineering approach to define functional humoral correlates of immunity against Ebola virus","volume":"54","author":"Gunn","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.xcrm.2023.100975_bib26","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.4049\/jimmunol.155.3.1165","article-title":"Ex\u00a0vivo coating of islet cell allografts with murine CTLA4\/Fc promotes graft tolerance","volume":"155","author":"Steurer","year":"1995","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.xcrm.2023.100975_bib27","doi-asserted-by":"crossref","first-page":"181","DOI":"10.4161\/mabs.2.2.11158","article-title":"Engineered Fc variant antibodies with enhanced ability to recruit complement and mediate effector functions","volume":"2","author":"Moore","year":"2010","journal-title":"mAbs"},{"key":"10.1016\/j.xcrm.2023.100975_bib28","doi-asserted-by":"crossref","first-page":"eaat7796","DOI":"10.1126\/sciimmunol.aat7796","article-title":"Antigen-specific antibody Fc glycosylation enhances humoral immunity via the recruitment of complement","volume":"3","author":"Lofano","year":"2018","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.xcrm.2023.100975_bib29","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.cell.2015.06.026","article-title":"Anti-HA glycoforms drive B cell affinity selection and determine influenza vaccine efficacy","volume":"162","author":"Wang","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2023.100975_bib30","doi-asserted-by":"crossref","first-page":"e02332-17","DOI":"10.1128\/mBio.02332-17","article-title":"NAction! how can neuraminidase-based immunity contribute to better influenza virus vaccines?","volume":"9","author":"Krammer","year":"2018","journal-title":"mBio"},{"key":"10.1016\/j.xcrm.2023.100975_bib31","doi-asserted-by":"crossref","first-page":"e01624-16","DOI":"10.1128\/mBio.01624-16","article-title":"Broadly neutralizing hemagglutinin stalk-specific antibodies induce potent phagocytosis of immune complexes by neutrophils in an Fc-dependent manner","volume":"7","author":"Mullarkey","year":"2016","journal-title":"mBio"},{"key":"10.1016\/j.xcrm.2023.100975_bib32","doi-asserted-by":"crossref","first-page":"e17377","DOI":"10.1371\/journal.pone.0017377","article-title":"A protective role for complement C3 protein during pandemic 2009 H1N1 and H5N1 influenza a virus infection","volume":"6","author":"O\u2019Brien","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.xcrm.2023.100975_bib33","first-page":"572","article-title":"On the doctrine of original antigenic sin","volume":"104","author":"Francis","year":"1960","journal-title":"Proc. Am. Phil. Soc."},{"key":"10.1016\/j.xcrm.2023.100975_bib34","doi-asserted-by":"crossref","first-page":"3308","DOI":"10.1128\/JVI.02871-14","article-title":"High preexisting serological antibody levels correlate with diversification of the influenza vaccine response","volume":"89","author":"Andrews","year":"2015","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.xcrm.2023.100975_bib35","doi-asserted-by":"crossref","first-page":"40027","DOI":"10.1038\/srep40027","article-title":"Antibody responses to trivalent inactivated influenza vaccine in health care personnel previously vaccinated and vaccinated for the first time","volume":"7","author":"Huang","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.xcrm.2023.100975_bib36","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1038\/nm.4224","article-title":"Molecular-level analysis of the serum antibody repertoire in young adults before and after seasonal influenza vaccination","volume":"22","author":"Lee","year":"2016","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2023.100975_bib37","first-page":"231","article-title":"In\u00a0vivo generation and clearance of soluble immune complexes containing IgM antibodies in normal and decomplemented rabbits","volume":"43","author":"Brown","year":"1981","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.xcrm.2023.100975_bib38","doi-asserted-by":"crossref","first-page":"127","DOI":"10.4049\/jimmunol.126.1.127","article-title":"Phagocytosis of immune complexes mediated by IgM and C3 receptors by macrophages from mice treated with glycogen","volume":"126","author":"Mantovani","year":"1981","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.xcrm.2023.100975_bib39","doi-asserted-by":"crossref","first-page":"e17223","DOI":"10.1371\/journal.pone.0017223","article-title":"IgM promotes the clearance of small particles and apoptotic microparticles by macrophages","volume":"6","author":"Litvack","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.xcrm.2023.100975_bib40","doi-asserted-by":"crossref","first-page":"520","DOI":"10.3389\/fimmu.2014.00520","article-title":"IgG subclasses and allotypes: from structure to effector functions","volume":"5","author":"Vidarsson","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.xcrm.2023.100975_bib41","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/nri2762","article-title":"Fc\u03b3RIIB in autoimmunity and infection: evolutionary and therapeutic implications","volume":"10","author":"Smith","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.xcrm.2023.100975_bib42","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/j.immuni.2013.02.023","article-title":"Endocytosis and recycling of immune complexes by follicular dendritic cells enhances B cell antigen binding and activation","volume":"38","author":"Heesters","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.xcrm.2023.100975_bib43","first-page":"69","article-title":"Prolonged antigen half-life in the lymphoid follicles of specifically immunized mice","volume":"37","author":"Tew","year":"1979","journal-title":"Immunology"},{"key":"10.1016\/j.xcrm.2023.100975_bib44","doi-asserted-by":"crossref","first-page":"12780","DOI":"10.1038\/ncomms12780","article-title":"A broadly neutralizing anti-influenza antibody reveals ongoing capacity of haemagglutinin-specific memory B cells to evolve","volume":"7","author":"Fu","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2023.100975_bib45","doi-asserted-by":"crossref","first-page":"5640","DOI":"10.1182\/blood-2012-01-380121","article-title":"Properties of mouse and human IgG receptors and their contribution to disease models","volume":"119","author":"Bruhns","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.xcrm.2023.100975_bib46","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1080\/19420862.2017.1323159","article-title":"Affinity of human IgG subclasses to mouse Fc gamma receptors","volume":"9","author":"Dekkers","year":"2017","journal-title":"mAbs"},{"key":"10.1016\/j.xcrm.2023.100975_bib47","doi-asserted-by":"crossref","first-page":"3430","DOI":"10.4049\/jimmunol.1200356","article-title":"Crosstalk between human IgG isotypes and murine effector cells","volume":"189","author":"Overdijk","year":"2012","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.xcrm.2023.100975_bib48","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/379346a0","article-title":"Augmented humoral and anaphylactic responses in FcyRll-deficient mice","volume":"379","author":"Takai","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2023.100975_bib49","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1084\/jem.20072565","article-title":"Distinct cell-specific control of autoimmunity and infection by Fc\u03b3RIIb","volume":"205","author":"Brownlie","year":"2008","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.xcrm.2023.100975_bib50","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.4049\/jimmunol.1302934","article-title":"Inhibitory Fc\u03b3 receptor is required for the maintenance of tolerance through distinct mechanisms","volume":"192","author":"Li","year":"2014","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.xcrm.2023.100975_bib51","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/s41586-020-2838-z","article-title":"Fc-optimized antibodies elicit CD8 immunity to viral respiratory infection","volume":"588","author":"Bournazos","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2023.100975_bib52","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.cell.2015.04.016","article-title":"Differential Fc-receptor engagement drives an anti-tumor vaccinal effect","volume":"161","author":"DiLillo","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2023.100975_bib53","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1093\/rheumatology\/kev433","article-title":"Fc-gamma receptor polymorphisms differentially influence susceptibility to systemic lupus erythematosus and lupus nephritis","volume":"55","author":"Tsang-A-Sjoe","year":"2016","journal-title":"Rheumatology"},{"key":"10.1016\/j.xcrm.2023.100975_bib54","doi-asserted-by":"crossref","first-page":"7881","DOI":"10.1073\/pnas.0915133107","article-title":"A defunctioning polymorphism in FCGR2B is associated with protection against malaria but susceptibility to systemic lupus erythematosus","volume":"107","author":"Willcocks","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2023.100975_bib55","doi-asserted-by":"crossref","first-page":"11931","DOI":"10.1073\/pnas.1609316113","article-title":"Epitope specificity plays a critical role in regulating antibody-dependent cell-mediated cytotoxicity against influenza A virus","volume":"113","author":"He","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2023.100975_bib56","doi-asserted-by":"crossref","first-page":"E5944","DOI":"10.1073\/pnas.1613225113","article-title":"Optimal activation of Fc-mediated effector functions by influenza virus hemagglutinin antibodies requires two points of contact","volume":"113","author":"Leon","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2023.100975_bib57","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/s41586-021-03530-2","article-title":"Adjuvanting a subunit COVID-19 vaccine to induce protective immunity","volume":"594","author":"Arunachalam","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2023.100975_bib58","doi-asserted-by":"crossref","first-page":"68","DOI":"10.3390\/pharmaceutics13010068","article-title":"Promising adjuvants and platforms for influenza vaccine development","volume":"13","author":"Zhu","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.xcrm.2023.100975_bib59","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/s41591-020-1118-7","article-title":"A chimeric hemagglutinin-based universal influenza virus vaccine approach induces broad and long-lasting immunity in a randomized, placebo-controlled phase I trial","volume":"27","author":"Nachbagauer","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2023.100975_bib60","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41541-019-0101-0","article-title":"Enhanced germinal center reaction by targeting vaccine antigen to major histocompatibility complex class II molecules","volume":"4","author":"Andersen","year":"2019","journal-title":"npj Vaccines"},{"key":"10.1016\/j.xcrm.2023.100975_bib61","doi-asserted-by":"crossref","first-page":"e0185666","DOI":"10.1371\/journal.pone.0185666","article-title":"Impact of age and pre-existing influenza immune responses in humans receiving split inactivated influenza vaccine on the induction of the breadth of antibodies to influenza A strains","volume":"12","author":"Nu\u00f1ez","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.xcrm.2023.100975_bib62","doi-asserted-by":"crossref","first-page":"462","DOI":"10.3390\/vaccines8030462","article-title":"High-yield expression and purification of recombinant influenza virus proteins from stably-transfected mammalian cell lines","volume":"8","author":"Ecker","year":"2020","journal-title":"Vaccines"},{"key":"10.1016\/j.xcrm.2023.100975_bib63","first-page":"e51112","article-title":"Expression of functional recombinant hemagglutinin and neuraminidase proteins from the novel H7N9 influenza virus using the baculovirus expression system","volume":"81","author":"Margine","year":"2013","journal-title":"J.\u00a0Vis. Exp."},{"key":"10.1016\/j.xcrm.2023.100975_bib64","doi-asserted-by":"crossref","first-page":"10493","DOI":"10.1128\/JVI.00959-08","article-title":"Structural characterization of the 1918 influenza virus H1N1 neuraminidase","volume":"82","author":"Xu","year":"2008","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.xcrm.2023.100975_bib65","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jim.2019.05.006","article-title":"A versatile high-throughput assay to characterize antibody-mediated neutrophil phagocytosis","volume":"471","author":"Karsten","year":"2019","journal-title":"J.\u00a0Immunol. Methods"},{"key":"10.1016\/j.xcrm.2023.100975_bib66","doi-asserted-by":"crossref","first-page":"112630","DOI":"10.1016\/j.jim.2019.07.002","article-title":"A high-throughput, bead-based, antigen-specific assay to assess the ability of antibodies to induce complement activation","volume":"473","author":"Fischinger","year":"2019","journal-title":"J.\u00a0Immunol. Methods"},{"key":"10.1016\/j.xcrm.2023.100975_bib67","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1128\/JCM.02045-09","article-title":"Influenza virus inactivation for studies of antigenicity and phenotypic neuraminidase inhibitor resistance profiling","volume":"48","author":"Jonges","year":"2010","journal-title":"J.\u00a0Clin. Microbiol."},{"key":"10.1016\/j.xcrm.2023.100975_bib68","first-page":"15G.1.1","article-title":"Influenza: propagation, quantification, and storage","volume":"29","author":"Balish","year":"2013","journal-title":"Curr. Protoc. Microbiol."},{"key":"10.1016\/j.xcrm.2023.100975_bib69","first-page":"4","article-title":"Hemagglutination inhibition (HI) assay of influenza viruses with monoclonal antibodies","volume":"6","author":"Wu","year":"2016","journal-title":"Bio-Protocol"}],"container-title":["Cell Reports Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379123000812?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379123000812?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T22:54:40Z","timestamp":1762988080000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666379123000812"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":69,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S2666379123000812"],"URL":"https:\/\/doi.org\/10.1016\/j.xcrm.2023.100975","relation":{},"ISSN":["2666-3791"],"issn-type":[{"value":"2666-3791","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pre-existing Fc profiles shape the evolution of neutralizing antibody breadth following influenza vaccination","name":"articletitle","label":"Article Title"},{"value":"Cell Reports Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xcrm.2023.100975","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors.","name":"copyright","label":"Copyright"}],"article-number":"100975"}}